Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain

ClinicalTrials.gov ID: NCT02104050

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT02104050. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 19, 2026, 2:41 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objectives of this trial are to investigate the efficacy and safety of six weeks of treatment with OLT1177 Gel in subjects with moderate to severe pain associated with osteoarthritis of the knee following cessation of pain therapy.

Study identification

NCT ID
NCT02104050
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Olatec Therapeutics, Inc.
Industry
Enrollment
202 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
45 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2014 (Type not available)
Primary completion
Aug 2015 (Actual)
Completion
Aug 2015 (Actual)
Last update posted
Oct 6, 2017

2014 – 2015

United States locations

U.S. sites
13
U.S. states
8
U.S. cities
13
Facility City State ZIP Site status
Achieve Clinical Research, LLC Birmingham Alabama 35216 —
Clinical Research Consulting, LLC Milford Connecticut 06460 —
Avail Clinical Research DeLand Florida 32720 —
Health Awareness, Inc. Jupiter Florida 33458 —
Sunrise Medical Research, Inc. Lauderdale Lakes Florida 33319 —
International Clinical Research - US, LLC Sanford Florida 32771 —
Miami Research Associates, LLC South Miami Florida 33143 —
Best Clinical Trial, LLC New Orleans Louisiana 70115 —
Healthcare Research Network, Inc. Hazelwood Missouri 63042 —
Omega Medical Research Warwick Rhode Island 02886 —
Clinical Trials of South Carolina Charleston South Carolina 29406 —
Coastal Carolina Research Center, Inc Mt. Pleasant South Carolina 29464 —
Charlottesville Medical Research Center, LLC Charlottesville Virginia 22911 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02104050, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 6, 2017 · Synced Nov 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.